source
- Epicrispr reports encouraging early data from EPI-321 in 12 patients with FSHDEpicrispr Biotechnologies released updated data on its epigenetic editing therapy EPI-321 aimed at treating facioscapulohumeral muscular dystrophy (FSHD). The company has now dosed twelve particip…
- Kyverna Therapeutics reports encouraging data for first CAR-T therapy targeting autoimmune diseaseKyverna Therapeutics released new data that strengthens its case for bringing the first CAR‑T treatment for an autoimmune condition to market. The results come after recent safety setbacks in simil…